RAP 0.00% 20.5¢ raptor resources limited

Ann: Broker Meets Biotech Presentation, page-10

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 2,708 Posts.
    lightbulb Created with Sketch. 505
    Another one that’s relative....disclaimer old post

    Hi @@ghoti,

    Your right, the possibility of changing the timeline to approval is remote or is it??

    Consider the situation of the new appointment of Trumpy & Dr Gottlieb.....
    Donald Trump is a business man with the need improve the spreadsheet & impress the people and the streamlining of the FDA is one of his best decisions to date.
    • The Dr's scope of appointment is untie the red tape on life saving innovations
    • Smart cough is not a drug or internal innovation, chance of side effects non existent
    • Trials being done in the best hospitals in the US (who chased us to be involved)
    • Being able for integration into the US Telehealth industry for instant results
    • Will save the US billions pa
    • Reduce over prescribing antibiotics
    I'm not saying Resapp will be the best product on the pre approval books next month....but we can't be to far off the mark can we??

    So if Dr Gottlieb is interested doing what he's getting payed for, impressing the boss and saving lifes Resapp health have just thing to make him look like a bloody superstar....

    TG
    Last edited by Tech goose: 09/08/18
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.